Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays

Gender-affirming hormonal therapies are a critical component of the care of transgender individuals. Transgender people are commonly prescribed estrogen or testosterone to promote male-to-female or female-to-male transitions and to preserve gender-specific characteristics long-term. However, some ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouck, Emma G., Grinsztejn, Eduarda, Mcnamara, Megan, Stavrou, Evi X., Wolberg, Alisa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562871/
https://www.ncbi.nlm.nih.gov/pubmed/37822706
http://dx.doi.org/10.1016/j.rpth.2023.102197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562871/
https://www.ncbi.nlm.nih.gov/pubmed/37822706
http://dx.doi.org/10.1016/j.rpth.2023.102197

Ejemplares similares